Search

everythinglearnresearchcommunity

for

Search:↓

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

A child's rare skin disease was triggered by chickenpox.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.

Early recognition and treatment of LPP can prevent hair loss and improve quality of life.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.

A rare case shows alopecia areata and ITP occurring together, needing more research.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Lupus nephritis can cause severe kidney and blood vessel problems.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Regular monitoring of autoantibodies in ANA-positive patients with hair loss helps detect and treat lupus early.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Platelet-rich plasma injections can help treat hair loss in lupus patients.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Hydroxychloroquine may cause nail discoloration in lupus patients.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Diagnosing and treating skin conditions is challenging, especially when drug reactions mimic other diseases.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.